邓甬川主任医师

科室：内科

擅长：专于乳腺良恶性肿瘤的诊断和治疗，尤其擅长乳腺癌的手术治疗、辅助治疗及新辅助和综合治疗。对乳腺癌的保留乳房和保腋窝手术有丰富的经验和... 完整擅长>>

简介：邓甬川，男，博士，教授，主任医师，博士生导师。现任浙江大学医学院附属第二医院肿瘤外科主任，乳腺肿瘤诊治中心主任，乳腺肿瘤病区主任。中国药学会委员，中国抗癌协会肿瘤化疗和抗癌药物专业委员会委员，浙江省医学会理事，浙江省医学会肿瘤学分会候任主任委员，肿瘤外科分会副主任委员，浙江省抗癌协会乳癌专业委员会副主任委员。
毕业于原浙江医科大学，1991年获博士学位，师从于我国著名的肿瘤学专家郑树教授和甄永苏院士。从事肿瘤临床工作已30余年，精于乳腺良恶性肿瘤的诊断和治疗，尤其擅长乳腺癌的手术治疗（根治术，保乳术，保腋术）、辅助治疗、新辅助治疗和综合治疗（放疗，化疗，内分泌治疗和靶向治疗等）。对乳腺癌的保留乳房手术和保腋窝手术有丰富的经验和很好的治疗效果。对复杂、疑难的乳腺癌治疗有独到的造诣。熟知乳癌治疗领域最新的国内外临床研究进展，并将最新成果应用于临床实践，为乳癌患者提供最新、最好、最适合的治疗。
承担或参加多项国家、省部级课题，发表SCI论文20篇。先后获1994年浙江省第四届青年科技奖，2003年教育部科技进步奖一等奖，2005年国家科技进步奖二等奖。
发表文章
1.Chen JQ, Tian W, Cai HK, He HF, Deng YC*. Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol, 2012; 29:2527-2534
2.Tian W, Chen JQ, He HF, Deng YC*. MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications. Clin Transl Oncol, 2012 Aug 23. [Epub ahead of print]
3.Zhou MQ, Hu XY, He HF, Chen JN, Chen LR, Deng YC*. Neoadjuvant HIFU treatment for malignant fibrous histiocytoma: report of a case. J Med Ultrasonics, 2012; 39: 259-264
4.Hu Y*, Li XZ, Deng YC, Zhou MQ, Zhang SZ. Primary Malignant Fibrous Histiocytoma of the Breast: A Case Report and Review of 38 Chinese Cases. Clinical Breast Cancer, 2012; 12 (5): 382-385
5.Cai HK, HF, Tian W, Zhou MQ, Hu Y, Deng YC*. Colorectal cancer lymph node staining by activated carbon nanoparticles suspension in vivo or methylene blue in vitro. World J Gastroenterol, 2012; 18(42): 6148-6154
6.Cai HK, Tian W, Zhou MQ, He HF, Hu Y and Deng YC*. Jejunal intussusception and polyps with different types of malignant transformation in Peutz Jeghers syndrome: Report of a case. Oncology Letters, 2013; 5: 239-241
7.Cai HK, Zhou MQ, Hu Y, He HF, Chen JQ, Tian W, Deng YC*. Solid-pseudopapillary neoplasms of the pancreas: clinical and pathological features of 33 cases. Surg Today, 2013; 43(2):148-154
8.Tian W, Deng YC, Li L, He HF, Sun J, XU D*. Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death. Int J Oncol, 2013; 42(2):721-732
9.Tian W, Xu D, Deng YC*. Honokiol, a multifunctional tumor cell death inducer. Pharmazie, 2012; 67: 811-816
10.He HF, Zhou MQ, Chen JQ, Tian W, Cai HK, Chen LR, Deng YC*. Enhanced Lymph Node Retrieval from Colorectal Cancer Resections using a Simple Lymphatic Staining Method. Hepatogastroenterology, 2012; 59(114): 375-379
11.Meng KX, Tian W, Zhou MQ, Chen HL, Deng YC*. Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels. World J Surg Oncol, 2013; 11:101
12.Li ZY, Tian W, Cai HK, Wang P, Deng YC*. Clinical manifestations and managements of post-neck dissection chylothorax. Chin Med J (Engl) 2013;126(13):2570-2572
13.Tian W, Xu D, Han W, He H, Cai H, Chen H, Zhou M, Chen J, Deng YC*. Cyclophilin D modulates cell death transition from early apoptosis to programmed necrosis induced by honokiol. Int J Oncol. 2013; 42(5):1654-1663
14.Hu XY, Cai HK, Zhou MQ, He HF, Tian W, Hu Y, Chen LR, Deng YC*. New clinical application of high-intensity focused ultrasound: local control of synovial sarcoma. World J Surgl Oncol 2013; 11:265-267